Positive clinical data reported at breast cancer symposium
Filed with ASX · · 2 pages · English
Imagion Biosystems Ltd. on 6ix
Earlier from Imagion Biosystems
- 2021 R&D Tax Refund
- Prostate cancer research update
- First-in-human Study Progress Update
- Full Year Results Release
- Half-year results release
Later from Imagion Biosystems
- Company Update - Phase 1 Study Independent Review
- Appendix 4E
- Imagion Secures Growth Funding
- Non-renounceable Entitlement Offer
- Imagion Funding Update
Follow Imagion Biosystems into a list and get an email when it puts out news.
Follow Imagion Biosystems